Puma Biotechnology (PBYI) Change in Cash (2011 - 2026)

Puma Biotechnology has reported Change in Cash for 16 years, with the latest figure at $6.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 205.96% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at -$26.8 million (down 95.59% YoY), and the FY2025 full-year result was -$39.6 million, down 157.61% from the prior year.
• Change in Cash for Q1 2026 stood at $6.6 million, up from -$23.9 million in the prior quarter.
• The five-year high for Change in Cash was $25.2 million in Q3 2022, with the low at -$23.9 million in Q4 2025.
• Historically, Change in Cash has averaged -$2.2 million across 5 years, with a median of -$1.8 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Cash surged 229.9% — and 2025, when it sank 1321.37%.
• Puma Biotechnology's Change in Cash stood at -$1.8 million in 2022, then surged by 229.9% to $2.3 million in 2023, then slipped by 14.4% to $2.0 million in 2024, then slumped by 1321.37% to -$23.9 million in 2025, then jumped by 127.45% to $6.6 million in 2026.
• The last three Change in Cash figures came in at $6.6 million (Q1 2026), -$23.9 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.